| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/12/2002 | WO2002070534A1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/12/2002 | WO2002070524A2 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/12/2002 | WO2002070523A1 Modulators of chemokine receptor activity |
| 09/12/2002 | WO2002070520A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070516A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 09/12/2002 | WO2002070515A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 09/12/2002 | WO2002070514A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | WO2002070498A1 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 09/12/2002 | WO2002070494A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 09/12/2002 | WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/12/2002 | WO2002070491A1 Nitrogenous heteroaromatic ring derivative having hiv integrase inhibitory activity |
| 09/12/2002 | WO2002070487A1 Substituted quinolinecarboxamides as antiviral agents |
| 09/12/2002 | WO2002070486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | WO2002070485A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070478A1 Indolone derivatives having vascular-damaging activity |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/12/2002 | WO2002070464A2 Hydrazones and their therapeutic use |
| 09/12/2002 | WO2002070462A1 Substituted amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070459A1 Novel amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070457A1 Inhibitor of monoamine uptake |
| 09/12/2002 | WO2002070070A2 Compositions having improved bioavailability of eletriptan |
| 09/12/2002 | WO2002070068A2 Lipoxin analogs as novel inhibitors of angiogenesis |
| 09/12/2002 | WO2002070008A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | WO2002070007A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | WO2002070001A2 Use of lp82 to treat hematopoietic disorders |
| 09/12/2002 | WO2002069994A2 Combined use of derivatives of glp-1 analogs and ppar ligands |
| 09/12/2002 | WO2002069992A1 Plant extracts and compositions comprising extracellular protease inhibitors |
| 09/12/2002 | WO2002069990A1 Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt |
| 09/12/2002 | WO2002069989A2 Aquatic animal treatment method and composition containing pimenta extract |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069968A1 New use |
| 09/12/2002 | WO2002069965A1 Benzimidazole derivatives as therapeutic agents |
| 09/12/2002 | WO2002069956A2 Use of carnitine for increasing testosteron |
| 09/12/2002 | WO2002069955A1 Method and formula for anti-tumor and anti-matastatic effect |
| 09/12/2002 | WO2002069948A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders |
| 09/12/2002 | WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
| 09/12/2002 | WO2002069944A2 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists |
| 09/12/2002 | WO2002069941A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | WO2002069906A2 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | WO2002069905A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | WO2002069896A2 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 09/12/2002 | WO2002069793A2 Extracorporeal blood processing information management system |
| 09/12/2002 | WO2002069740A1 Compositions containing creatine and creatinine |
| 09/12/2002 | WO2002062851A8 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 09/12/2002 | WO2002057409A3 Antisense modulation of src-2 expression |
| 09/12/2002 | WO2002053099A3 Methods and compositions for treating periodontal disease |
| 09/12/2002 | WO2002050030A3 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
| 09/12/2002 | WO2002044187A3 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 09/12/2002 | WO2002032375A8 Uses of monoclonal antibody 8h9 |
| 09/12/2002 | WO2002028862A3 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002007748A3 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/12/2002 | WO2002002096A3 Oral compositions comprising host-response modulating agent |
| 09/12/2002 | WO2001096334A3 Heteroarylalkanoic acids as integrin receptor antagonists |
| 09/12/2002 | WO2001089558A3 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
| 09/12/2002 | WO2001089530A3 Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator |
| 09/12/2002 | WO2001089520A3 Dehydroascorbic acid formulations and uses thereof |
| 09/12/2002 | WO2001083529A3 Immunoadhesin for the prevention of rhinovirus infection |
| 09/12/2002 | WO2001068078A3 Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/12/2002 | WO2001047562A3 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 09/12/2002 | WO2001045681A3 Naphthoquinone derivatives as cd45 inhibitors |
| 09/12/2002 | WO2001045641A3 Inhibitors of thrombin induced platelet aggregation |
| 09/12/2002 | WO2001041768A9 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 09/12/2002 | WO2001034174A3 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 09/12/2002 | WO2001020034A3 Methods and compositions for the screening of cell cycle modulators |
| 09/12/2002 | WO2001015694A9 Extended duration light activated cancer therapy |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000065091A3 Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression |
| 09/12/2002 | US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species |
| 09/12/2002 | US20020128553 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/12/2002 | US20020128483 Sulfonamide-containing indole compounds |
| 09/12/2002 | US20020128480 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 09/12/2002 | US20020128477 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 09/12/2002 | US20020128447 Pharmaceutical composition containing IL-10 |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128319 Abeta 42 lowering agents |
| 09/12/2002 | US20020128307 Tetramic acid-type compounds isolated from a CCR-5 active complex produced by fermentation under controlled conditions of a biologically pure culture of the microorganism, Chaetomium globosum Kunze |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128304 Administering as anticarcinogenic agent |
| 09/12/2002 | US20020128302 Use of a CB1 receptor antagonist for the preparation of drugs useful in the treatment of appetency disorders, such as obesity associated with non-insulin- dependent diabetes and drug dependence |
| 09/12/2002 | US20020128298 Methods for increasing leptin levels using nicotinic acid compounds |
| 09/12/2002 | US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/12/2002 | US20020128289 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 09/12/2002 | US20020128288 Useful in the treatment of chronic and acute pain. |
| 09/12/2002 | US20020128287 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/12/2002 | US20020128280 Administering (1) a farnesyl protein transferase inhibitor and (2) a tyrosine kinase inhibitor. |
| 09/12/2002 | US20020128278 Inhibit some of the ill effects caused by diabetes or by aging; preventing premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/12/2002 | US20020128276 Administering an estrogen agonist/ antagonist; lowering vaginal pH; treating an urinary tract infection; treating vaginal dryness, itching, undesired spasms, and vaginitis; treating undesired urinary frequency or incontinence |
| 09/12/2002 | US20020128271 N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 09/12/2002 | US20020128270 Treating stroke, arhtritis, cancer, tissue ulceration, decubitis ulcer, restenosis, periodontal disease, epidermolysis bullosa, scleritis, psoriasis, AIDS, sepsis, and septic shock. |